Global medicine R&D has shown a stabilized trend after fleeting prosperity lately. Despite of discouraging whole picture. the role of China in cross-border out-licensing activities of medical therapeutics keeps rising. which started since 2020 and further boosted in 2023. https://www.kingarte.com/product-category/industrialrestaurant-business-8/